{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:16:42Z","timestamp":1773281802242,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ajoc.2016.09.004","type":"journal-article","created":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T04:37:29Z","timestamp":1475296649000},"page":"78-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Subcutaneous repository corticotropin gel for non-infectious panuveitis: Reappraisal of an old pharmacologic agent"],"prefix":"10.1016","volume":"4","author":[{"given":"Aniruddha","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasir J.","family":"Sepah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana V.","family":"Do","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2016.09.004_bib1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ophtha.2015.10.028","article-title":"Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis","volume":"123","author":"Dick","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2016.09.004_bib2","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2016.09.004_bib3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000438951","article-title":"Sirolimus for retinal and uveitic diseases","volume":"55","author":"Agarwal","year":"2016","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.ajoc.2016.09.004_bib4","first-page":"310329","article-title":"Emerging therapies for noninfectious uveitis: what may be coming to the clinics","volume":"2014","author":"Maya","year":"2014","journal-title":"J\u00a0Ophthalmol"},{"key":"10.1016\/j.ajoc.2016.09.004_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.smim.2015.02.003","article-title":"ACTH: the forgotten therapy","volume":"27","author":"Montero-Melendez","year":"2015","journal-title":"Seminars Immunol"},{"key":"10.1016\/j.ajoc.2016.09.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.06.022","article-title":"Targeting melanocortin receptors as potential novel therapeutics","volume":"111","author":"Getting","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajoc.2016.09.004_bib7","doi-asserted-by":"crossref","first-page":"8016","DOI":"10.1073\/pnas.92.17.8016","article-title":"Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone","volume":"92","author":"Star","year":"1995","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.ajoc.2016.09.004_bib8","first-page":"1","article-title":"The role of alpha-MSH as a modulator of ocular immunobiology exemplifies mechanistic differences between melanocortins and steroids","author":"Clemson","year":"2016","journal-title":"Ocular Immunol Inflamm"},{"key":"10.1016\/j.ajoc.2016.09.004_bib9","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1100\/tsw.2010.173","article-title":"The melanocortin system in control of inflammation","volume":"10","author":"Catania","year":"2010","journal-title":"Sci World J"},{"key":"10.1016\/j.ajoc.2016.09.004_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.97.3.375","article-title":"High-dose corticotropin (ACTH) versus prednisone for infantile spasms: a prospective, randomized, blinded study","volume":"97","author":"Baram","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajoc.2016.09.004_bib11","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1177\/0961203314532562","article-title":"Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial","volume":"23","author":"Fiechtner","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.ajoc.2016.09.004_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/DDDT.S33110","article-title":"Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series","volume":"6","author":"Levine","year":"2012","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.ajoc.2016.09.004_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000339287","article-title":"Treatment of resistant glomerular diseases with adrenocorticotropic hormone gel: a prospective trial","volume":"36","author":"Bomback","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ajoc.2016.09.004_bib14","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.transproceed.2015.07.013","article-title":"Complete remission of post-transplantation recurrence of focal segmental glomerulosclerosis with the use of adrenocorticotrophic hormone gel: case report","volume":"47","author":"Mittal","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ajoc.2016.09.004_bib15","first-page":"1570","article-title":"A\u00a0pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar(R) Gel) in nephrotic syndrome due to idiopathic membranous nephropathy","volume":"29","author":"Hladunewich","year":"2014","journal-title":"Nephrol Dialysis, Transplant Official Publ Eur Dialysis Transpl Assoc - Eur Ren Assoc"},{"key":"10.1016\/j.ajoc.2016.09.004_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2147\/DDDT.S19331","article-title":"Five-day regimen of intramuscular or subcutaneous self-administered adrenocorticotropic hormone gel for acute exacerbations of multiple sclerosis: a prospective, randomized, open-label pilot trial","volume":"5","author":"Simsarian","year":"2011","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.ajoc.2016.09.004_bib17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.12688\/f1000research.7192.1","article-title":"Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: a retrospective study of patients","volume":"4","author":"Li","year":"2015","journal-title":"F1000Research"},{"key":"10.1016\/j.ajoc.2016.09.004_bib18","series-title":"Tolerability, and Bioactivity of Tocilizumab on Patients with Non-infectious UVEITIS: The STOP-UVEITIS Study (STOP-uveitis)","author":"Study of the Safety","year":"2012"},{"key":"10.1016\/j.ajoc.2016.09.004_bib19","first-page":"79","article-title":"Cortisone and ACTH in therapy of uveitis","volume":"1","author":"Moutinho","year":"1953","journal-title":"Rev Port Med Mil"},{"key":"10.1016\/j.ajoc.2016.09.004_bib20","first-page":"372","article-title":"Sympathetic ophthalmia cured by cortisone and ACTH","volume":"35","author":"Sturman","year":"1956","journal-title":"Eye, Ear, Nose Throat Mon"},{"key":"10.1016\/j.ajoc.2016.09.004_bib21","first-page":"105","article-title":"A\u00a0ten-year follow-up on a case of sympathetic ophthalmia","volume":"68","author":"DeVoe","year":"1970","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajoc.2016.09.004_bib22","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjo.57.9.704","article-title":"Beh\u00e7et's disease with recurrent facial paralysis","volume":"57","author":"Aggarwal","year":"1973","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2016.09.004_bib23","first-page":"1010","article-title":"Acute diffuse choroiditis; Harada's disease; treatment with ACTH","volume":"107","author":"Nano","year":"1955","journal-title":"La Sem Medica"},{"key":"10.1016\/j.ajoc.2016.09.004_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2007-0027","article-title":"Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in\u00a0vitro and in\u00a0vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases","volume":"29","author":"Brzoska","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ajoc.2016.09.004_bib25","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.4049\/jimmunol.161.6.2873","article-title":"Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents","volume":"161","author":"Manna","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajoc.2016.09.004_bib26","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/(SICI)1097-4547(19991201)58:5<684::AID-JNR9>3.0.CO;2-#","article-title":"Autocrine alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human glioma","volume":"58","author":"Ichiyama","year":"1999","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.ajoc.2016.09.004_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.56.1.1","article-title":"Targeting melanocortin receptors as a novel strategy to control inflammation","volume":"56","author":"Catania","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ajoc.2016.09.004_bib28","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.4049\/jimmunol.1300182","article-title":"Both MC5r and A2Ar are required for protective regulatory immunity in the spleen of post-experimental autoimmune uveitis in mice","volume":"191","author":"Lee","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajoc.2016.09.004_bib29","doi-asserted-by":"crossref","first-page":"8862","DOI":"10.1167\/iovs.11-8153","article-title":"Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen","volume":"52","author":"Lee","year":"2011","journal-title":"Investigative Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajoc.2016.09.004_bib30","series-title":"Acthar Gel (Repository Corticotropin Injection)","author":"Full Prescribing Information H.P.","year":"2015"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993616301268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993616301268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:55:21Z","timestamp":1762527321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993616301268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":30,"alternative-id":["S2451993616301268"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2016.09.004","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous repository corticotropin gel for non-infectious panuveitis: Reappraisal of an old pharmacologic agent","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2016.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}